Filter
579
Text search:
laboratory
biosafety
Featured
Recommendations
97
New Publications
135
Language
Document type
No document type
271
Guidelines
145
Studies & Reports
59
Manuals
56
Strategic & Response Plan
25
Training Material
8
Fact sheets
6
Situation Updates
5
Resource Platforms
3
Brochures
1
Countries / Regions
India
33
Sierra Leone
17
Latin America and the Carribbean
17
Western and Central Europe
17
Nigeria
16
Africa
16
Global
14
Kenya
12
Ghana
11
Rwanda
11
Eastern Europe
11
Uganda
10
Brazil
10
Liberia
9
Zambia
8
West and Central Africa
8
Ethiopia
7
Mozambique
7
Ukraine
7
East and Southern Africa
7
Philippines
6
Tanzania
6
Bangladesh
6
Angola
6
Middle East and North Africa
6
Congo, Democratic Republic of
5
Nepal
5
South–East Asia Region
5
Russia
5
Syria
4
Namibia
4
Eastern Europe and Central Asia
4
Spain
4
Guinea
3
Guinea-Bissau
3
Pakistan
3
South Africa
3
Malawi
3
Western Pacific Region
3
Tajikistan
3
Burkina Faso
2
Cameroon
2
Germany
2
Myanmar / Burma
2
Senegal
1
USA
1
Saudi Arabia
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Mauritania
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Colombia
1
Yemen
1
Asia
1
Poland
1
Italy
1
Laos
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Georgia
1
Vietnam
1
North America
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
203
Pharmacy & Technologies
59
Clinical Guidelines
50
Key Resources
24
Public Health
21
Women & Child Health
6
Capacity Building
3
Toolboxes
COVID-19
127
TB
104
Ebola & Marburg
60
Rapid Response
60
2.0 Rapid Response
42
AMR
37
NTDs
21
HIV
14
Zika
12
Conflict
9
Polio
8
Caregiver
8
Pharmacy
7
Planetary Health
6
Natural Hazards
4
Specific Hazards
4
Cholera
3
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Malaria
2
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.
Ebola Virus Disease Outbreak Response Plan in West Africa July to December 2014. Annex 1
Draft version 2017
A new respiratory infectious disease, COVID-19, caused by a new coronavirus called SARS-CoV-2, emerged in early December 2019. Since then, the virus has spread to India and 106 other countries in Asia, Europe, North America, Africa, and Oceania. On March 11, the World Health Organization (WHO) decl
...
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
The aim of the pandemic preparedness checklist is primarily to provide an outline of the essential minimum elements of preparedness, as well as elements of preparedness that are considered desirable. It is recommended that responsible authorities or institutes in countries that are in the process of
...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
Policy statement.
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y l
...
Technical and operational ‘how-to’: practical considerations
